{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:55:19Z","timestamp":1782435319699,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Teleflex"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00270-020-02460-2","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T12:02:36Z","timestamp":1585742556000},"page":"897-903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Uterine Fibroid Embolization (UFE) with Optisphere: A Prospective Study of a New, Spherical, Resorbable Embolic Agent"],"prefix":"10.1007","volume":"43","author":[{"given":"Nigel","family":"Hacking","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Vigneswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"2460_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(95)92282-2","volume":"346","author":"JH Ravina","year":"1995","unstructured":"Ravina JH, Herbreteau D, Ciraru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. Lancet. 1995;346:671\u20132.","journal-title":"Lancet"},{"key":"2460_CR2","first-page":"1540","volume":"23","author":"JH Ravina","year":"1994","unstructured":"Ravina JH, Merland JJ, Herbreteau D, Houdart E, Bouret JM, Madelenat P. Preoperative embolization of uterine fibroma. Preliminary results (10 cases). Presse Med. 1994;23:1540.","journal-title":"Presse Med"},{"key":"2460_CR3","doi-asserted-by":"publisher","first-page":"519.e1","DOI":"10.1016\/j.ajog.2007.02.029","volume":"196","author":"NA Volkers","year":"2007","unstructured":"Volkers NA, Hehenkamp WJK, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2\u00a0years\u2019 outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2007;196:519.e1\u201311.","journal-title":"Am J Obstet Gynecol"},{"key":"2460_CR4","doi-asserted-by":"publisher","unstructured":"Critchley H, Horne A. Faculty of 1000 evaluation for Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy\u2013results from the randomized clinical Embolisation versus Hysterectomy (EMMY) Trial. F1000\u2014Post-publication peer review of the biomedical literature. 2008. https:\/\/doi.org\/10.3410\/f.1104365.560383.","DOI":"10.3410\/f.1104365.560383"},{"key":"2460_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiol.2303030111","volume":"230","author":"J-P Pelage","year":"2004","unstructured":"Pelage J-P, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology. 2004;230:803\u20139.","journal-title":"Radiology"},{"key":"2460_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00270-007-9187-2","volume":"31","author":"T Katsumori","year":"2008","unstructured":"Katsumori T, Kasahara T, Kin Y, Nozaki T. Infarction of uterine fibroids after embolization: relationship between postprocedural enhanced MRI findings and long-term clinical outcomes. Cardiovasc Intervent Radiol. 2008;31:66\u201372.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2460_CR7","doi-asserted-by":"publisher","unstructured":"Worthington-Kirsch RL, Hughes LA. Uterine artery embolization\u2014vascular anatomic considerations and procedure techniques. Uterine Fibroids. 2003. pp. 83\u201390. https:\/\/doi.org\/10.1017\/cbo9780511550218.013.","DOI":"10.1017\/cbo9780511550218.013"},{"key":"2460_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00270-013-0790-0","volume":"37","author":"R Das","year":"2014","unstructured":"Das R, Champaneria R, Daniels JP, Belli A-M. Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis. Cardiovasc Intervent Radiol. 2014;37:1179\u201390.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2460_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1053\/j.semperi.2008.04.007","volume":"32","author":"G Mari","year":"2008","unstructured":"Mari G, Hanif F. Fetal doppler: umbilical artery, middle cerebral artery, and venous system. Semin Perinatol. 2008;32:253\u20137.","journal-title":"Semin Perinatol"},{"key":"2460_CR10","doi-asserted-by":"publisher","unstructured":"Eid ME-S, Eid ME-S, Taye AM. Impaired uterine perfusion in infertile women with repeated IVF-implantation failure as detected by uterine artery color Doppler study. Fertility and Sterility. 2009. p. S118. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.07.1126.","DOI":"10.1016\/j.fertnstert.2009.07.1126"},{"key":"2460_CR11","doi-asserted-by":"publisher","unstructured":"Laurent A, Pelage J-P, Wassef M, Martal J. Fertility after bilateral uterine artery embolization in a sheep model. Fertility and Sterility. 2008. pp. 1371\u20131383. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.03.058.","DOI":"10.1016\/j.fertnstert.2007.03.058"},{"key":"2460_CR12","first-page":"25","volume":"33","author":"A Laurent","year":"2017","unstructured":"Laurent A, Moine L. The new biomaterials of embolization: the shift to degradable. Med Sci. 2017;33:25\u201331.","journal-title":"Med Sci."},{"key":"2460_CR13","unstructured":"Medtronic Minneapolis U. Instructions for Use-Optisphere Embospheres. 2018 Oct. Available: http:\/\/manuals.medtronic.com\/content\/dam\/emanuals\/spinal\/102339_rD_IFUOptiSphere_Embolization_Spheres_Intl_LLC.pdf."},{"key":"2460_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1055\/s-0028-1085930","volume":"25","author":"S Vaidya","year":"2008","unstructured":"Vaidya S, Tozer K, Chen J. An overview of embolic agents. Semin Intervent Radiol. 2008;25:204\u201315. https:\/\/doi.org\/10.1055\/s-0028-1085930.","journal-title":"Semin Intervent Radiol"},{"key":"2460_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s42155-018-0044-y","author":"R Yadavali","year":"2019","unstructured":"Yadavali R, Ananthakrishnan G, Sim M, Monaghan K, McNaught G, Hamoodi I, et al. Randomised trial of two embolic agents for uterine artery embolisation for fibroids: Gelfoam versus Embospheres (RAGE trial). CVIR Endovascular. 2019. https:\/\/doi.org\/10.1186\/s42155-018-0044-y.","journal-title":"CVIR Endovascular"},{"key":"2460_CR16","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.pathol.2016.12.038","volume":"49","author":"R Norman","year":"2017","unstructured":"Norman R. Assessing ovarian reserve\u2014AMH and its opportunities and disadvantages. Pathology. 2017;49:S15\u20136.","journal-title":"Pathology"},{"key":"2460_CR17","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1097\/01.RVI.0000179793.69590.1A","volume":"16","author":"JB Spies","year":"2005","unstructured":"Spies JB, Allison S, Flick P, Cramp M, Bruno J, Jha RC, et al. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. J Vasc Interv Radiol. 2005;16:1431\u20137.","journal-title":"J Vasc Interv Radiol"},{"key":"2460_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jvir.2007.08.034","volume":"19","author":"GP Siskin","year":"2008","unstructured":"Siskin GP, Beck A, Schuster M, Mandato K, Englander M, Herr A. Leiomyoma infarction after uterine artery embolization: a prospective randomized study comparing tris-acryl gelatin microspheres versus polyvinyl alcohol microspheres. J Vasc Interv Radiol. 2008;19:58\u201365.","journal-title":"J Vasc Interv Radiol"},{"key":"2460_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/01.RVI.0000136982.42548.5D","volume":"15","author":"JB Spies","year":"2004","unstructured":"Spies JB, Allison S, Flick P, McCullough M, Sterbis K, Cramp M, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a randomized comparative study. J Vasc Interv Radiol. 2004;15:793\u2013800.","journal-title":"J Vasc Interv Radiol"},{"key":"2460_CR20","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2214\/AJR.05.0640","volume":"186","author":"T Katsumori","year":"2006","unstructured":"Katsumori T, Kasahara T, Akazawa K. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR Am J Roentgenol. 2006;186:848\u201354.","journal-title":"AJR Am J Roentgenol"},{"key":"2460_CR21","doi-asserted-by":"publisher","unstructured":"Morimoto K, Chono S, Kosai T, Seki T, Tabata Y. Design of Cationic Microspheres Based on Aminated Gelatin for Controlled Release of Peptide and Protein Drugs. Drug Delivery. 2008. pp. 113\u2013117. https:\/\/doi.org\/10.1080\/10717540801905124.","DOI":"10.1080\/10717540801905124"},{"key":"2460_CR22","doi-asserted-by":"publisher","unstructured":"Tamilvanan S. Progress in the design of biodegradable polymer-based microspheres for parenteral controlled delivery of therapeutic peptide\/protein. Pharmaceutical Manufacturing Handbook. pp. 393\u2013441. https:\/\/doi.org\/10.1002\/9780470259818.ch12.","DOI":"10.1002\/9780470259818.ch12"},{"key":"2460_CR23","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/0284185117694510","volume":"58","author":"J Bengtsson","year":"2017","unstructured":"Bengtsson J, Cwikiel W, Sundgren PC, Karlstam E, Gavier-Wid\u00e9n D, Keussen I. The effects of uterine artery embolization with a new degradable microsphere in an experimental study. Acta Radiol. 2017;58:1334\u201341. https:\/\/doi.org\/10.1177\/0284185117694510.","journal-title":"Acta Radiol"},{"key":"2460_CR24","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00330-018-5692-8","volume":"29","author":"R Iezzi","year":"2019","unstructured":"Iezzi R, Pompili M, Rinninella E, Annicchiarico E, Garcovich M, Cerrito L, et al. TACE with degradable starch microspheres (DSM\u2013TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib. Eur Radiol. 2019;29:1285\u201392.","journal-title":"Eur Radiol"},{"key":"2460_CR25","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1016\/j.biomaterials.2005.01.050","volume":"26","author":"R Cheung","year":"2005","unstructured":"Cheung R, Ying Y, Rauth A, Marcon N, Yuwu X. Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Biomaterials. 2005;26:5375\u201385. https:\/\/doi.org\/10.1016\/j.biomaterials.2005.01.050.","journal-title":"Biomaterials"},{"key":"2460_CR26","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10856-010-4080-y","volume":"21","author":"REJ Forster","year":"2010","unstructured":"Forster REJ, Th\u00fcrmer F, Wallrapp C, Lloyd AW, Macfarlane W, Phillips GJ, et al. Characterisation of physico-mechanical properties and degradation potential of calcium alginate beads for use in embolisation. J Mater Sci Mater Med. 2010;21:2243\u201351. https:\/\/doi.org\/10.1007\/s10856-010-4080-y.","journal-title":"J Mater Sci Mater Med"},{"key":"2460_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00270-011-0218-7","volume":"35","author":"RJ Owen","year":"2012","unstructured":"Owen RJ, Nation PN, Polakowski R, Biliske JA, Tiege PB, Griffith IJ. A preclinical study of the safety and efficacy of Occlusin\u2122 500 artificial embolization device in sheep. Cardiovasc Intervent Radiol. 2012;35:636\u201344.","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00270-020-02460-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-020-02460-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T23:21:56Z","timestamp":1617146516000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00270-020-02460-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1007\/s00270-020-02460-2","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nigel Hacking has received honoraria from Boston Scientific and Celonova as a speaker and has been on Advisory boards for BTG. Tim Bryant has proctored for Boston Scientific and Terumo and has received speaker honorariums from Boston Scientific. Sachin Modi has received a speaker honorarium from Boston Scientific. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This study was approved by the institutional review board (IRB), regional ethics committee and national regulatory body.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}